Aviso Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$614K Sell
4,404
-303
-6% -$42.4K 0.28% 77
2025
Q4
$578K Buy
4,707
+778
+20% +$94.5K 0.24% 84
2025
Q3
$436K Sell
3,929
-6
-0.2% -$682 0.19% 97
2025
Q2
$436K Buy
3,935
+531
+16% +$56.5K 0.2% 96
2025
Q1
$381K Sell
3,404
-17
-0.5% -$1.75K 0.2% 101
2024
Q4
$316K Sell
3,421
-259
-7% -$23.3K 0.16% 110
2024
Q3
$309K Sell
3,680
-82
-2% -$6.26K 0.17% 114
2024
Q2
$258K Sell
3,762
-148
-4% -$9.88K 0.15% 124
2024
Q1
$286K Buy
3,910
+140
+4% +$10.8K 0.18% 119
2023
Q4
$305K Buy
+3,770
New +$293K 0.22% 105

Other funds holding GILD

Aviso Wealth Management's GILD Position: Q1 2026 in Review

Aviso Wealth Management reduced its Gilead Sciences (GILD) stake by 6.4% in Q1 2026, selling an estimated $42.4K and leaving 4,404 shares worth $614K. The position accounts for 0.28% of the portfolio, ranked #77.

Aviso Wealth Management first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Aviso Wealth Management held 4,404 shares of Gilead Sciences worth $614K as of Q1 2026.
  • Aviso Wealth Management sold 303 Gilead Sciences shares in Q1 2026, an estimated $42.4K.
  • Gilead Sciences made up 0.28% of Aviso Wealth Management's portfolio in Q1 2026, its #77 holding.
  • Aviso Wealth Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Aviso Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.